Our observation that the combination of PTEN and PIK3CA gene copy number more strongly related to outcome than either marker alone is consistent with recent results reported in breast cancer patients treated with trastuzumab Berns et al (2007). This evidence concerns the gene PIK3CA and breast carcinoma.